White House White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds September 22, 2023Vol.49 No.35By Matthew Bin Han Ong
Cancer History ProjectFreeIn the Archives New biography shows how Mary Lasker used money and clout to make the National Cancer Act happen September 22, 2023Vol.49 No.35
Conversation with The Cancer Letter After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation September 15, 2023Vol.49 No.34By Paul Goldberg
Capitol Hill Obstacles cleared for Bertagnolli’s confirmation as NIH directorSenate HELP Committee schedules hearing September 15, 2023Vol.49 No.34By Matthew Bin Han Ong
IU Simon’s healthy breast tissue biobank now seeks to understand how breast cancer develops—in men September 15, 2023Vol.49 No.34By Matthew Bin Han Ong
FreeGuest Editorial The insinuation that AstroTurf causes GBM has no basis in scienceThe Philadelphia Inquirer series does disservice to brain tumor community September 15, 2023Vol.49 No.34By Henry S. Friedman and Kyle M. Walsh
FreeObituary David Alberts, founding member of the University of Arizona Cancer Center, dies at 83 September 15, 2023Vol.49 No.34By Lisa M. Dahm and Mark Anthony Febbo
FreeIn the Archives In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch September 15, 2023Vol.49 No.34By Deborah Doroshow and Alexandria Carolan
Conversation with The Cancer LetterFree Shelley Earp steps down at UNC Lineberger, ending a 22-year directorshipA search for his replacement begins September 08, 2023Vol.49 No.33By Paul Goldberg
White House Just one cancer drug—ibrutinib—figures on the CMS list of 10 drugs subject to price negotiations under Medicare Part DPhRMA sues to block the program September 08, 2023Vol.49 No.33By Matthew Bin Han Ong
